Success Metrics

Clinical Success Rate
100.0%

Based on 16 completed trials

Completion Rate
100%(16/16)
Active Trials
10(29%)
Results Posted
31%(5 trials)

Phase Distribution

Ph phase_4
3
9%
Ph not_applicable
25
71%
Ph phase_1
3
9%
Ph phase_2
3
9%

Phase Distribution

3

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution34 total trials
Phase 1Safety & dosage
3(8.8%)
Phase 2Efficacy & side effects
3(8.8%)
Phase 4Post-market surveillance
3(8.8%)
N/ANon-phased studies
25(73.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

16 of 18 finished

Non-Completion Rate

11.1%

2 ended early

Currently Active

10

trials recruiting

Total Trials

35

all time

Status Distribution
Active(12)
Completed(16)
Terminated(2)
Other(5)

Detailed Status

Completed16
Recruiting9
unknown5
Withdrawn2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
35
Active
10
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (8.8%)
Phase 23 (8.8%)
Phase 43 (8.8%)
N/A25 (73.5%)

Trials by Status

not_yet_recruiting13%
unknown514%
active_not_recruiting13%
completed1646%
enrolling_by_invitation13%
recruiting926%
withdrawn26%

Recent Activity

Clinical Trials (35)

Showing 20 of 35 trialsScroll for more
NCT07332143Phase 2

Psilocybin-Assisted Therapy

Not Yet Recruiting
NCT06723834Not Applicable

Service Dogs and Prolonged Exposure Therapy for Military-Connected PTSD

Enrolling By Invitation
NCT03624218Not Applicable

Outcomes After Spinal Cord Injury (OASIS)

Completed
NCT04961190Phase 4

A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD

Active Not Recruiting
NCT05974631Not Applicable

Evaluating Treatments for Suicidal Veterans With PTSD

Recruiting
NCT04626050Not Applicable

General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19

Recruiting
NCT06953687Not Applicable

Shared Decision Making in PTSD Treatment

Recruiting
NCT06296589Not Applicable

Trauma-Informed Guilt Reduction Therapy Compared to Prolonged Exposure

Recruiting
NCT06296186Not Applicable

Massed Prolonged Exposure for PTSD in Substance Use Treatment

Recruiting
NCT06288711Not Applicable

Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD

Recruiting
NCT04104022Not Applicable

Prolonged Exposure Therapy for PTSD and Opioid Use Disorder

Completed
NCT06705296Phase 1

Deep Brain Stimulation for Refractory PTSD

Recruiting
NCT04327362Not Applicable

TDCS-Augmented Prolonged Exposure Therapy

Withdrawn
NCT04581434Not Applicable

Psychotherapy for PTSD Among Veterans Also Receiving Drug or Alcohol Treatment

Completed
NCT06279598Not Applicable

PT-STRESS Study: Predicting Treatment Success and Dealing With Non-response in the Treatment of PTSD

Recruiting
NCT05709353Phase 2

MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder

Recruiting
NCT04236284Not Applicable

Management of Chronic Pain and PTSD in Gulf War Veterans With tDCS+Prolonged Exposure

Completed
NCT01911585Not Applicable

Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure

Completed
NCT00739765Not Applicable

Effectiveness of Three Different Psychotherapies for Chronic Post-Traumatic Stress Disorder

Completed
NCT01524133Phase 4

PROlonGed ExpoSure Sertraline

Completed

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
35